<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25083">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01940614</url>
  </required_header>
  <id_info>
    <org_study_id>CODDI2013</org_study_id>
    <nct_id>NCT01940614</nct_id>
  </id_info>
  <brief_title>Use of Copeptin in Diabetes Insipidus</brief_title>
  <official_title>Use of Copeptin in the Differential Diagnosis of Diabetes insipidus-a Prospective International Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective evaluation of the novel biomarker copeptin in the differential diagnosis of
      diabetes insipidus against the standard diagnostic test methods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose of this study is to compare the overall diagnostic accuracy of the three following
      diagnostic test procedures in diabetes insipidus (central, nephrogen) and primary
      polydipsia: a) classical water deprivation test alone, b) classical water deprivation test
      plus plasma copeptin cut-off levels, c) hypertonic saline infusion test plus plasma copeptin
      measurement.

      The investigators hypothesize that firstly b) and c) is better as a). Secondly the
      investigators hypothesize that c) is non-inferior to b).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Discriminative value of copeptin during different diagnostic tests.</measure>
    <time_frame>beginning and end of protocol, up to 8hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Diabetes Insipidus (Central and Nephrogen)</condition>
  <condition>Primary Polydipsia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water deprivation test</intervention_name>
    <description>Classical water deprivation test alone</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water deprivationtest</intervention_name>
    <description>classical water deprivation test plus plasma copeptin cut-off levels</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypertonic saline infusion</intervention_name>
    <description>hypertonic saline infusion test plus plasma copeptin measurement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Polyuria or/and Polydipsia or/and therapy with synthetic AVP derivate

          -  Urine osmolality &lt;800mOsm/kgH20

        Exclusion Criteria:

          -  Polyuria due to diabetes mellitus

          -  Hypokalemia

          -  Hyperkalemia (&gt;5mmol/l)

          -  Hypercalcemia

          -  Kidney disease (min.: GFR 60ml/min/1.73m2)

          -  Pregnancy

          -  Hyponatremia &gt;135mmol/L

          -  Hypernatremia &gt;145mmol/L

          -  Hypo- or hypervolemia

          -  uncorrected adrenal or thyroidal deficiency

          -  Cardia failure

          -  Epilepsia

          -  Uncontrolled hypertension
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mirjam Christ-Crain</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mirjam Christ-Crain, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mirjam Christ-Crain, Prof. Dr. med.</last_name>
    <phone>0041 61 265 2525</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Univerisity Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>Basel-Stadt</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirjam Christ-Crain, Prof. Dr. med.</last_name>
      <phone>+41612652525</phone>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 12, 2013</lastchanged_date>
  <firstreceived_date>September 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Mirjam Christ-Crain</investigator_full_name>
    <investigator_title>Pfor.Dr.med</investigator_title>
  </responsible_party>
  <keyword>Copeptin</keyword>
  <keyword>differential diagnosis of polyuria polydipsia syndrome</keyword>
  <keyword>diabetes insipidus</keyword>
  <keyword>compulsive water drinking</keyword>
  <keyword>water deprivation test</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Insipidus</mesh_term>
    <mesh_term>Diabetes Insipidus, Neurogenic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
